Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3

DRUG Stock  USD 39.18  1.07  2.81%   
Roughly 54% of Bright Minds' stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Bright Minds Biosciences suggests that some traders are interested. The current market sentiment, together with Bright Minds' historical and current headlines, can help investors time the market. In addition, many technical investors use Bright Minds Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Bright Minds Biosciences 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 184331 common shares at 21.7 of Bright Minds by Cormorant Asset Management, Lp on 4th of November 2024. This event was filed by Bright Minds Biosciences with SEC on 2024-11-04. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Bright Minds' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bright Minds' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Bright Minds Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Bright Minds can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bright Minds Fundamental Analysis

We analyze Bright Minds' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Minds using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Minds based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Bright Minds is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Bright Minds Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bright Minds stock to make a market-neutral strategy. Peer analysis of Bright Minds could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics with similar companies.

Peers

Bright Minds Related Equities

IMMXImmix Biopharma   19.39   
0%
100.0%
PYXSPyxis Oncology   3.39   
0%
17.0%
REVBRevelation Biosciences   0.67   
0%
3.0%
NRBONeurobo Pharmaceuticals   0.43   
0%
2.0%
PHIOPhio Pharmaceuticals   0.00   
0%
0%
ADTXAditxt   0.29   
1.0%
0%
UNCYUnicycive Therapeutics   0.29   
1.0%
0%
ZURAZura Bio   0.33   
1.0%
0%
ELEVElevation Oncology   0.89   
4.0%
0%
ZVSAZyVersa Therapeutics   3.60   
18.0%
0%
CYTOAltamira Therapeutics   4.17   
21.0%
0%
DRMADermata Therapeutics   4.35   
22.0%
0%
RNAZTranscode Therapeutics   9.71   
50.0%
0%

Complementary Tools for Bright Stock analysis

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities